ORIGINAL RESEARCH

 

A pilot study on the efficacy of Valeriana officinalis mother tincture and Valeriana officinalis 3X in the treatment of attention deficit hyperactivity disorder

 

 

Radmila Razlog; Janice Pellow; Sally J. White

Department of Homoeopathy, University of Johannesburg, South Africa

Correspondence

 

 

---

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder characterised by inattention, impulsivity and hyperactivity. Valeriana officinalis is a botanical medicine that has been found to be beneficial in the treatment of disorders characterised by restlessness. To date, no research has been conducted on homeopathic preparations of Valeriana officinalis for this condition. The aim of this three-week, double-blind, placebo-controlled pilot study was to determine the efficacy of homeopathic Valeriana officinalis mother tincture (MT) and 3X potency on ADHD. Thirty children between the ages of five and 11 years, pre-diagnosed with ADHD, were recruited. Valeriana officinalis MT (n = 10), 3X (n = 10) or placebo (n = 10) were administered orally three times a day for two weeks. Efficacy was assessed by the Barkley and DuPaul teacher rating scale, the children's checking task and the parent symptom questionnaire scores on day 1 (prior to treatment), at the end of weeks two and three (with treatment), and then after the third week following no treatment. A statistically significant improvement was found in the participants' behaviour in the MT and 3X groups, with particular reference to sustained attention, anxiety and impulsivity and/or hyperactivity. Preliminary findings suggested that Valeriana officinalis MT and 3X may have applications in the management of ADHD.

---

OPSOMMING

Aandagsgebrek-hiperaktiwiteitsindroom (AGHS) is toenemend 'n algemene gedragsongesteldheid, wat gekenmerk word deur onoplettendheid, impulsiwiteit en hiperaktiwiteit. Daar is vasgestel dat Valeriana officinalis 'n plantaardige medisyne is wat voordelig kan wees in die behandeling van ongesteldhede wat gekenmerk word deur rusteloosheid. Tot op hede is geen navorsing uitgevoer op die gebruik van homeopatiese preparate van Valeriana officinalis vir hierdie ongesteldheid nie. Die doel van hierdie drieweeklange, dubbelblinde, troosmedisyne-gekontroleerde loodsstudie was om die effektiwiteit van homeopatiese Valeriana officinalis Moertinktuur (MT) en 3X sterkte vir die behandeling van AGHS te bepaal. Dertig kinders tussen die ouderdomme van 5 en 11 jaar, wat vantevore gediagnoseer is met OGHO, is gewerf. Valeriana officinalis MT (n = 10), 3X (n = 10) of troosmedisyne (n = 10) is mondeliks drie keer per dag vir twee weke toegedien. Effektiwiteit is gemeet op dag 1 (voor behandeling), aan die einde van weke twee en drie (tydens behandeling), en na die derde week sonder behandeling deur middel van tellings wat behaal is op die Barkley and DuPaul teacher rating scale, die children's checking task en die parent symptom questionnaire. 'n Statisties beduidende verbetering is gevind in die gedrag van die deelnemers in die MT en 3X groepe, in die besonder met betrekking tot volgehoue oplettendheid, angstigheid en impulsiwiteit en/of hiperaktiwiteit. Voorlopige bevindinge dui daarop dat Valeriana officinalis MT en 3X moontlik gebruik kan word in die behandeling van AGHS.

---

 

 

“Full text available only in PDF format”

 

 

References

American Psychiatric Association, 2000, Diagnostic and statistical manual of mental disorders, 4th edn., text rev., American Psychiatric Association, Washington, DC.         [ Links ]

Aschenbrenner, D., 2006, 'Strattera: A new black box warning', American Journal of Nursing 106(1), 33. http://dx.doi.org/10.1097/00000446-200601000-00024; http://dx.doi.org/10.1097/00000446-200604000-00024        [ Links ]

Balch, P.A., 2002, Prescription for Herbal Healing, Avery, New York.         [ Links ]

Barkley, R.A., 1998, Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment, Guilford Press, New York.         [ Links ]

Barkley, R.A., 2005, Take charge of ADHD: The complete authoritative guide for parents, Hinkler Books, Dingley. PMCid:2847347        [ Links ]

Beers, M.H., Berkwits, M., Jones, T.V., Kaplan, J.L. & Porter R.S. (eds.), 2006, The Merck manual, 18th edn., Merck Research Laboratories, Rahway.         [ Links ]

Berdonces, J.L., 2001, 'Attention deficit and infantile hyperactivity', Revista Espanola de Enfermedades Digestivas 24(1), 11-14.         [ Links ]

Bilia, A.R., Eterno, F., Bergonzi, M.C., Mazzi, G. & Vincieri, F.F., 2007, 'Evaluation of the content and stability of the constituents of mother tinctures and tinctures: The case ofCrataegusoxyacantha L. andHieracium pilosella L.', Journal ofPharmaceutical and Biomedical Analysis 44(1), 70-78. http://dx.doi.org/10.1016/j.jpba.2007.01.046 PMid:17331690        [ Links ]

Blumenthal, M., 1998, The complete German Commission E monographs: Therapeutic guide to herbal medicines, American Botanical Council, Austin.         [ Links ]

Boericke, W., 2001, Pocket manual of homoeopathic materia medica and repertory, 9th edn., B. Jain Publishers, New Delhi.         [ Links ]

Clarke, A.R., Barry, R.J., McCarthy, R. & Selikowitz, M., 2002, 'EEG analysis of children with attention-deficit/hyperactivity disorder and comorbid reading disabilities', Journal of Learning Disabilities 35(3), 276-286. http://dx.doi.org/10.1177/002221940203500309, PMid:15493324        [ Links ]

Cordes, M. & McLaughlin, T.F., 2004, 'Attention deficit hyperactivity disorder and rating scales with a brief review of the Connor's teacher rating scale (1998)', International Journal of Special Education 19(2), 23-34.         [ Links ]

Davari-Ashtiani, R., Shahrbabaki, M.E., Razjouyan, K., Amini, H. & Mazhabdar, H., 2010, 'Child buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: A double-blind and randomized trial', Psychiatry of Human Development 41, 641-648. http://dx.doi.org/10.1007/s10578-010-0193-2, PMid:20517641        [ Links ]

DrugLib.com, n.d., Concerta (Methylphenidate Hydrochloride) - Side effects and adverse Reactions, viewed 23 March 2010, from http://www.druglib.com/druginfo/concerta/side-effects_adverse-reactions/        [ Links ]

DuPaul, G. & Weyandt, L., 2006, 'School-based interventions for children and adolescents with attention-deficit/hyperactivity disorder: Enhancing academic and behavioural outcomes', Education and Treatment of Children 29(2), 341-358.         [ Links ]

European Medicines Agency, 2007, 'Committee on herbal medicinal products (HMPC) assessment report on Valeriana officinalis L., radix', Doc. Ref. EMEA/ HMPC/167391/2006, p. 16, viewed 23 March 2011, from http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_ report/2009/12/WC500017929.pdf        [ Links ]

Fox, J.A., 1997, Primary health care of children, Mosby, Maryland Heights.         [ Links ]

Frei, H. & Thurneysen, A., 2001, 'Treatment for hyperactive children: Homeopathy and methylphenidate compared in a family setting', British Homeopathic Journal 90(4), 178-179. http://dx.doi.org/10.1054/homp.1999.0506        [ Links ]

Frei, H., Everts, R., Von Ammon, K., Kaufmann, F., Walther, D., Hsu-Schmitz, S.F. et al., 2005, 'Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial', European Journal of Pediatrics 166(5), 509.         [ Links ]

Frenkel, O., 2008, 'A phenomenology of the "Placebo Effect": Taking meaning from the mind to the body', Journal of Medicine and Philosophy 33(1), 58-79. http://dx.doi.org/10.1093/jmp/jhm005; PMid:18420551        [ Links ]

Goyette, C.H., Conners, C.K. & Ulrich, R.F., 1978, 'Normative data on revised Conner's parent and teacher rating scales', Journal of Abnormal Psychology 6, 231-236. http://dx.doi.org/10.1007/BF00919127        [ Links ]

Grieve, M., 2003, A modern herbal: Valerian, viewed 24 March 2010, from http://www.botanical.com/botanical/mgmh/v/valeri01.html        [ Links ]

Guo, R., Mao, D.A., Li, J.M., Luo, X.M., Jiang, Y. & Liu, J.H., 2011, 'Investigation on the behaviour problems of children aged 3 to 5 years in Changsha and comparison of the norm of Conner's parent symptom questionnaire in Chinese and American urban children', Zhongguo Dang Dai Er Ke Za Zhi 13(11), 900-903. PMid:22099201        [ Links ]

Hobbs, C., 1993, Valerian: The relaxing and sleep herb, Botanica Press, Santa Cruz.         [ Links ]

Johnson, W.L., Gilliam, B., Johnson, A.M., Mcwilliams, E. & Avula, A., 2005, The nature, clinical assessment, and treatment of children with attention deficit hyperactivity disorder (ADHD): A review of the literature, The University of Texas, Tyler.         [ Links ]

Kayne, S.B., 1997, Homeopathic pharmacy, theory and practice, 2nd edn., Elsevier Churchill Livingstone, Philadelphia.         [ Links ]

Kemper, K., Gardiner, P. & Chan, E., 2000, '"At least it's natural ... " Herbs and dietary supplements in ADHD', Contemporary Pediatrics 9, 116.         [ Links ]

Kemper, K.J., 1999, 'Valerian (Valeriana officinalis), in The Longwood Herbal Taskforce and The Center for Holistic Pediatric Education and Research, viewed 24 October 2012, from http://www.longwoodherbal.org/valerian/valerian.pdf        [ Links ]

Koetter, U., 2009, 'Valerian and hops: Synergy, mode of action, and clinical evidence', in R. Cooper & F. Kronenberg (eds.), Botanical medicine, from bench to bedside, pp. 154-166, Mary Ann Liebert, Inc., New Rochelle.         [ Links ]

Mosby's Medical Dictionary, 2009, 8th edn., Elsevier, St Louis.         [ Links ]

Murphy, K., Kubin, Z.J., Shepherd, J.N. & Ettinger, R.H., 2009, 'Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats', Phytomedicine 17(8-9), 674-678. PMid:20042323        [ Links ]

National Institute of Mental Health, 2006, Brain changes mirror symptoms in ADHD, viewed 04 April 2008, from http://www.nimh.nih.gov/science-news/2006/brain-changes-mirror-symptoms-in-adhd.shtml        [ Links ]

Nichols, S.L. & Waschbusch, D.A., 2004, 'A review of the validity of laboratory cognitive tasks used to assess symptoms of ADHD', Child Psychiatry and Human Development 34(4), 297-315. http://dx.doi.org/10.1023/B:CHUD.0000020681.06865.97; PMid:15039603        [ Links ]

Picton, H., 2005, Hyperactivity and ADD: Caring and coping, Witwatersrand University Press, Johannesburg.         [ Links ]

Power, T.J., Russell, H.F., Soffer, S.L., Blom-Hoffman, J. & Grim, S.M., 2002, 'Role of parent training in the effective management of attention deficit/hyperactivity disorder', Disease Management and Health Outcomes 10, 117-126. http://dx.doi.org/10.2165/00115677-200210020-00007        [ Links ]

Schain, R. & Oetinger, L., 1978, Attention, behaviour and drugs in hyperactive children: The psychologist, the school and the child with MBD/LD, Grure and Stratton, Inc., New York. PMCid:1238063        [ Links ]

Scholte, E.M., Van Berckelaar-Onnes, I.A. & Van Der Ploeg, J.D., 2010, 'DSM-IV related ADHD symptom ratings by professional caretakers in residential treatment centres', Journal of Child Psychology and Psychiatry 42, 341-346. http://dx.doi.org/10.1111/1469-7610.00727        [ Links ]

Smith, L.A., Terre Blanche, M.J. & Solomon, E.M., 2001, 'The effect of Cerbo® and Nerva 2® on attention deficit hyperactivity disorder', MTech dissertation, Department of Homoeopathy, Technikon Witwatersrand.         [ Links ]

Vermeulen, F., 1997, Concordant materia medica, Emryss bv Publishers, Haarlem.         [ Links ]

Vermeulen, F., 2004, Prisma, the arcana of materia medica illuminated, 3rd edn., Emryss bv Publishers, Haarlem.         [ Links ]

Wilens, T., 2008, 'New advances in the psychopharmacological treatment of attention-deficit/hyperactivity disorder', American Academy of Child & Adolescent Psychiatry (Online), viewed 31 July 2008, from http://www.aacap.org/cs/root/developmentor/new_advances _in_the_psychopharmacological_treatment_of_ attentiondeficit/hyperactivity_disorder        [ Links ]

Xin, B., Guo, L.T., Li, X.R., Shan Y.H., Fang, H., Liu, K.Z. et al., 2009, 'Quality of life of children with attention deficit hyperactivity disorders', Sichuan Xue Bao Yi Xue Ban 40(6), 1091-1095.         [ Links ]

 

 

Correspondence:
Radmila Razlog
PO Box 17011
Doornfontein 2028
South Africa
Email: radmilar@uj.ac.za

Received 25 May 2011
Accepted: 28 Aug. 2012
Published: 10 Dec. 2012